StockData
Freenome, Inc. logo

Freenome, Inc. (FRNM) stock

FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$10.41−0.20 (-1.89%)

Close on Nov 13, 2026Market cap $1.15BP/E –Yield –

Freenome statistics

57 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$1.15B
$1.68B
Enterprise Value
$973.78M
$2.20B
PB Ratio
2.40
3.46
P/TBV Ratio
2.46
5.80
P/OCF Ratio
14.05
14.68

Enterprise valuationIndustry

EV / EBITDA
3.88
16.14
EV / EBIT
3.88
20.51

Share statisticsIndustry

Float
72M
34M
Shares Held by Insiders
35.3%
15.4%
Shares Held by Institutions
8.02%
83.6%

Short sellingIndustry

Short Interest
5M
–
Short Interest Change
3.35%
-0.86%
Short % of Float
6.46%
6.28%
Short % of Shares Outstanding
4.18%
4.21%
Days to Cover
8.08
4.41

Stock price statisticsIndustry

52-Week High
$17.50
–
52-Week Low
$9.71
–
20-Day Moving Average
$12.00
–
50-Day Moving Average
$13.97
–
200-Day Moving Average
$12.37
–
Average True Range (14)
$0.99
–
Price Change (1 Week)
2.26%
0.23%
Price Change (1 Month)
-15.3%
-0.02%
Price Change (3 Months)
-19.9%
2.13%
Price Change (6 Months)
-6.05%
17.6%
Price Change (YTD)
-20.1%
5.22%
Price Change (1 Year)
-3.35%
3.75%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
780,512
–
Average Volume (90 Days)
799,624
–
Relative Volume
0.77
0.70
Relative Strength Index (14)
35.7
46.0
Volatility (1 Year)
51.1%
64.2%
Beta (5 Years)
0.23
0.76

Returns on capitalIndustry

Return on Equity (ROE)
35.5%
4.82%
Return on Assets (ROA)
26.5%
-3.10%
Return on Invested Capital (ROIC)
109.2%
4.69%
Return on Capital Employed (ROCE)
36.0%
0.40%

Financial positionIndustry

Current Ratio
12.73
1.41
Quick Ratio
5.23
0.99

EfficiencyIndustry

Profits Per Employee
$5.76M
-$5.12K
Employee Count
19
910
WACC
7.60%
8.40%

Income statement (TTM)Industry

Operating Income
$250.71M
-$675.66K
Net Income
$109.43M
-$1.48M
EBITDA
$250.71M
$1.17M

Balance sheetIndustry

Net Cash (Debt)
$180.38M
$203.66K
Net Cash Per Share
$1.63
$0.00
Equity (Book Value)
$481.33M
$235.60M
Book Value Per Share
$4.34
$3.91
Tangible Book Value
$468.33M
$1.59M
Working Capital
$424.79M
$30.06M

Cash flow (TTM)Industry

Operating Cash Flow
$82.12M
$25.90M

Dividends and yieldsIndustry

Earnings Yield
9.48%
0.19%

Scores and fair valueIndustry

Altman Z-Score
1.86
2.24

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodFRNMS&P 500DifferenceFRNM per yearS&P 500 per year
1 month-17.6%-3.0%−14.6 pts
3 months-10.3%-2.8%−7.6 pts
Year to date-20.1%+11.5%−31.6 pts
1 year-3.5%+13.5%−17.0 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M FRNM shares were sold short on Oct 30, 2026, up 3.3% from the previous report, or 6.46% of the shares available to trade. At recent volumes it would take 8.1 days to buy them back. Over the last 20 sessions, 49.6% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20264,633,222+3.3%573,5368.1
Oct 15, 20264,483,175+31.9%803,0495.6
Sep 30, 20263,400,130+100.4%1,040,3593.3
Sep 15, 20261,696,752+10.8%791,4222.1
Aug 31, 20261,531,137+8.1%906,6711.7
Aug 14, 20261,416,509+217.8%808,7421.8
Jul 31, 2026445,737–598,0211.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?